SCHEMBL31669183

SCHEMBL31669183

N[C@@H]1CCN(C(=O)Oc2cccc3cccnc23)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.54
▸ LMNA P02545 3/20 0.51
▸ METAP2 P50579 1/20 0.51
▸ METAP1 P53582 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.47
▸ POLB P06746 1/20 0.46
▸ PRSS1 P07477 1/20 0.46
▸ ACR P10323 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.45
▸ USP2 O75604 1/20 0.44
▸ CNR1 P21554 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31669378 0.80 RAB9A (0.52) LMNAALDH1A1POLBL3MBTL1MEN1
SCHEMBL31669409 0.77 ALDH1A1 (0.50) KDM4ELMNAALDH1A1MAPTMEN1
SCHEMBL31669152 0.76 TP53 (0.44) ALDH1A1POLBKMT2AHSD17B10ALOX15
SCHEMBL31669155 0.76 TP53 (0.44) ALDH1A1POLB
SCHEMBL31669098 0.75 SMN1; SMN2 (0.41) KDM4ELMNAALDH1A1POLBMAPT
SCHEMBL7873483 0.75 LMNA (0.52) KDM4ELMNAMETAP2METAP1HDAC6
SCHEMBL31669375 0.74 GAA (0.41) LMNAPOLBMAPTL3MBTL1HTT
SCHEMBL31669414 0.73 RAB9A (0.50) KDM4ELMNAALDH1A1POLBL3MBTL1
SCHEMBL31669103 0.73 TP53 (0.42) ALDH1A1MEN1KMT2A
SCHEMBL31669191 0.73 EPHX1 (0.46) ALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors MERTK, RET, ERBB2 KDM4E 1635/4885LMNA 1144/4885METAP2 1664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback